Firmenseite:
Zur Website
Expansion:
national
Jobs für Ingenieure, Informatiker, Mediziner & Naturwissenschaftler
CatalYm GmbH
Planegg
Deine Karriere bei CatalYm
The pioneer for GDF-15
targeting in immuno-oncology
CatalYm has identified GDF-15 as a key regulator of the immune system in the tumor microenvironment. We are pioneering the reversal of GDF-15-mediated immunosuppression to induce a potent antitumoral immune reaction in nonresponsive tumors.
CatalYm’s lead program, CTL-002, is poised to demonstrate clinical proof-of-concept in multiple solid tumor indications and has the potential to expand the treatment horizon for current and future immunotherapies.
targeting in immuno-oncology
CatalYm has identified GDF-15 as a key regulator of the immune system in the tumor microenvironment. We are pioneering the reversal of GDF-15-mediated immunosuppression to induce a potent antitumoral immune reaction in nonresponsive tumors.
CatalYm’s lead program, CTL-002, is poised to demonstrate clinical proof-of-concept in multiple solid tumor indications and has the potential to expand the treatment horizon for current and future immunotherapies.
Bewerbung & Berufseinstieg bei CatalYm
Bewerbungswege
- Direkt-Bewerbung über jobvector
- Online-Bewerbung
Firmendaten zu CatalYm
Dein Job bei uns: Wen wir suchen
Ideale Fachrichtungen für Bewerber
Beliebte Jobs bei uns
Top Skills & Kenntnisse für unsere Stellenangebote
Standort
CatalYm GmbH
Am Klopferspitz 19
82152 Planegg
Deutschland
